New possibilities of infliximab administration in chronic inflammatory rheumatic diseases

Bibliographic Details
Main Authors: A. I. Dubikov, E E Medved, E E Medved'
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2005-04-01
Series:Научно-практическая ревматология
Online Access:https://rsp.mediar-press.net/rsp/article/view/1670
id doaj-265f73585e614fe1a2089eb3ac746ea0
record_format Article
spelling doaj-265f73585e614fe1a2089eb3ac746ea02021-08-02T09:05:35ZrusIMA-PRESS LLCНаучно-практическая ревматология1995-44841995-44922005-04-01432767910.14412/1995-4484-2005-15321607New possibilities of infliximab administration in chronic inflammatory rheumatic diseasesA. I. DubikovE E MedvedE E Medved'https://rsp.mediar-press.net/rsp/article/view/1670
collection DOAJ
language Russian
format Article
sources DOAJ
author A. I. Dubikov
E E Medved
E E Medved'
spellingShingle A. I. Dubikov
E E Medved
E E Medved'
New possibilities of infliximab administration in chronic inflammatory rheumatic diseases
Научно-практическая ревматология
author_facet A. I. Dubikov
E E Medved
E E Medved'
author_sort A. I. Dubikov
title New possibilities of infliximab administration in chronic inflammatory rheumatic diseases
title_short New possibilities of infliximab administration in chronic inflammatory rheumatic diseases
title_full New possibilities of infliximab administration in chronic inflammatory rheumatic diseases
title_fullStr New possibilities of infliximab administration in chronic inflammatory rheumatic diseases
title_full_unstemmed New possibilities of infliximab administration in chronic inflammatory rheumatic diseases
title_sort new possibilities of infliximab administration in chronic inflammatory rheumatic diseases
publisher IMA-PRESS LLC
series Научно-практическая ревматология
issn 1995-4484
1995-4492
publishDate 2005-04-01
url https://rsp.mediar-press.net/rsp/article/view/1670
work_keys_str_mv AT aidubikov newpossibilitiesofinfliximabadministrationinchronicinflammatoryrheumaticdiseases
AT eemedved newpossibilitiesofinfliximabadministrationinchronicinflammatoryrheumaticdiseases
AT eemedved newpossibilitiesofinfliximabadministrationinchronicinflammatoryrheumaticdiseases
_version_ 1721236152590008320